The diagnostic value of the Short Physical Performance Battery for sarcopenia

Steven Phu, Ben Kirk, Ebrahim Bani Hassan, Sara Vogrin, Jesse Zanker, Solange Bernardo, Gustavo Duque, Steven Phu, Ben Kirk, Ebrahim Bani Hassan, Sara Vogrin, Jesse Zanker, Solange Bernardo, Gustavo Duque

Abstract

Background: Sarcopenia is defined as the age-related loss of muscle mass, strength, and physical performance. The original European Working Group on Sarcopenia in Older Persons (EWGSOP1) definition, and its revision (EWGSOP2), provide new cut-points and alternate measures for sarcopenia diagnosis. However, sarcopenia is rarely diagnosed in clinical settings owing to its labor-intensive diagnostic process. Given the Short Physical Performance Battery (SPPB) is a quick, easily administrable, and objective measure of muscle strength and physical performance, both of which are key components of sarcopenia, this study examined the diagnostic value of the SPPB for this muscle disease.

Methods: A cross-sectional analysis of 294 community-dwelling older persons (≥65 years) was conducted. Appendicular lean body mass [(ALM) divided by height squared (ALM/h2)], muscle strength (handgrip/sit to stand), and physical performance [gait speed, timed up and go (TUG) and SPPB] were assessed using validated procedures, while participants were diagnosed with sarcopenia following the EWGSOP1 and EWGSOP2 criteria. Diagnostic ability of the SPPB independently and combined with ALM/h2 for sarcopenia was determined using area under the curve (AUC). Potential cut-points were identified, and sensitivity and specificity calculated.

Results: Prevalence of sarcopenia ranged from 4 to 16% depending on the definition. The SPPB demonstrated moderate (AUC = 0.644-0.770) value in diagnosing sarcopenia, and a cut-point of ≤8points in SPPB performance resulted in high sensitivity (82-100%) but low specificity (36-41%) for diagnosing those with severe sarcopenia.

Conclusions: The SPPB displayed acceptable value in diagnosing older adults with severe sarcopenia. Moreover, the high sensitivity of the SPPB when using the cut-point of ≤8 suggests it may be a favorable screening tool for sarcopenia in clinical settings where ALM measurements are not available.

Keywords: Ageing; Diagnosis; Sarcopenia; Short physical performance battery.

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Rizzoli R, Reginster JY, Arnal JF, Bautmans I, Beaudart C, Bischoff-Ferrari H, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int. 2013;93(2):101–120. doi: 10.1007/s00223-013-9758-y.
    1. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7(5):512–514. doi: 10.1002/jcsm.12147.
    1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi: 10.1093/ageing/afq034.
    1. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
    1. Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium [published online ahead of print, 2020 Mar 9]. J Am Geriatr Soc. 2020. 10.1111/jgs.16372.
    1. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–256. doi: 10.1016/j.jamda.2011.01.003.
    1. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. doi: 10.1016/j.jamda.2013.11.025.
    1. Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36. doi: 10.1002/jcsm.12048.
    1. Phu S, Vogrin S, Zanker J, Bani Hassan E, Al Saedi A, Duque G. Agreement between initial and revised European working group on sarcopenia in older people definitions. people definitions. J Am Med Dir Assoc. 2019;20(3):382–3.e1.
    1. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–M94. doi: 10.1093/geronj/49.2.M85.
    1. Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C. Development and initial validation of the falls efficacy scale-international (FES-I) Age Ageing. 2005;34(6):614–619. doi: 10.1093/ageing/afi196.
    1. Podsiadlo D, Richardson S. The timed "up & go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–148. doi: 10.1111/j.1532-5415.1991.tb01616.x.
    1. Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315–1316. doi: 10.1097/JTO.0b013e3181ec173d.
    1. Liu X. Classification accuracy and cut point selection. Stat Med. 2012;31(23):2676–2686. doi: 10.1002/sim.4509.
    1. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35. doi: 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>;2-3.
    1. Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biom J. 2005;47(4):458–472. doi: 10.1002/bimj.200410135.
    1. Fisher S, Ottenbacher KJ, Goodwin JS, Graham JE, Ostir GV. Short physical performance battery in hospitalized older adults. Aging Clin Exp Res. 2009;21(6):445–452. doi: 10.1007/BF03327444.
    1. Stookey AD, Katzel LI, Steinbrenner G, Shaughnessy M, Ivey FM. The short physical performance battery as a predictor of functional capacity after stroke. J Stroke Cerebrovasc Dis. 2014;23(1):130–135. doi: 10.1016/j.jstrokecerebrovasdis.2012.11.003.
    1. Bernabeu-Mora R, Gimenez-Gimenez LM, Montilla-Herrador J, Garcia-Guillamon G, Garcia-Vidal JA, Medina-Mirapeix F. Determinants of each domain of the short physical performance battery in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2539–2544. doi: 10.2147/COPD.S138402.
    1. Owusu C, Margevicius S, Schluchter M, Koroukian SM, Berger NA. Short physical performance battery, usual gait speed, grip strength and vulnerable elders survey each predict functional decline among older women with breast cancer. J Geriatr Oncol. 2017;8(5):356–362. doi: 10.1016/j.jgo.2017.07.004.
    1. Zhang F, Ferrucci L, Culham E, Metter EJ, Guralnik J, Deshpande N. Performance on five times sit-to-stand task as a predictor of subsequent falls and disability in older persons. J Aging Health. 2013;25(3):478–492. doi: 10.1177/0898264313475813.
    1. Buatois S, Perret-Guillaume C, Gueguen R, Miget P, Vancon G, Perrin P, et al. A simple clinical scale to stratify risk of recurrent falls in community-dwelling adults aged 65 years and older. Phys Ther. 2010;90(4):550–560. doi: 10.2522/ptj.20090158.
    1. Fritz S, Lusardi M. White paper: "walking speed: the sixth vital sign". J Geriatr Phys Ther. 2009;32(2):46–49. doi: 10.1519/00139143-200932020-00002.
    1. Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 2006;54(5):743–749. doi: 10.1111/j.1532-5415.2006.00701.x.
    1. Liguori I, Russo G, Aran L, Bulli G, Curcio F. Della-Morte, et al. sarcopenia: assessment of disease burden and strategies to improve outcomes. Clin Interv Aging. 2018;13:913–927. doi: 10.2147/CIA.S149232.
    1. Tieland M, Verdijk LB, de Groot LC, van Loon LJ. Handgrip strength does not represent an appropriate measure to evaluate changes in muscle strength during an exercise intervention program in frail older people. Int J Sport Nutr Exerc Metab. 2015;25(1):27–36. doi: 10.1123/ijsnem.2013-0123.
    1. Veronese N, Bolzetta F, Toffanello ED, Zambon S, De Rui M, Perissinotto E, et al. Association between short physical performance battery and falls in older people: the Progetto Veneto Anziani study. Rejuvenation Res. 2014;17(3):276–284. doi: 10.1089/rej.2013.1491.
    1. Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr. 2012;31(5):652–658. doi: 10.1016/j.clnu.2012.02.007.
    1. Lalkhen AG, McCluskey A. Clinical tests: sensitivity and specificity. Contin Educ Anaesth Crit Care Pain. 2008;8(6):221–223. doi: 10.1093/bjaceaccp/mkn041.
    1. Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc. 2014;15(9):630–634. doi: 10.1016/j.jamda.2014.04.021.
    1. Barbosa-Silva TG, Menezes AM, Bielemann RM, Malmstrom TK, Gonzalez MC. Grupo de Estudos em Composicao corporal e N. enhancing SARC-F: improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc. 2016;17(12):1136–1141. doi: 10.1016/j.jamda.2016.08.004.
    1. Schaap LA, Koster A, Visser M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons. Epidemiol Rev. 2013;35:51–65. doi: 10.1093/epirev/mxs006.
    1. Kim YH, Kim KI, Paik NJ, Kim KW, Jang HC, Lim JY. Muscle strength: a better index of low physical performance than muscle mass in older adults. Geriatr Gerontol Int. 2016;16(5):577–585. doi: 10.1111/ggi.12514.
    1. Sepulveda-Loyola W, Phu S, Bani Hassan E, Brennan-Olsen SL, Zanker J, Vogrin S, et al. The Joint Occurrence of Osteoporosis and Sarcopenia (Osteosarcopenia): Definitions and Characteristics. J Am Med Dir Assoc. 2020;21(2):220–5.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi